GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $12.37 $18.22 Thursday, 18th Apr 2024 URGN stock ended at $14.26. This is 0.140% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.15% from a day low at $13.96 to a day high of $14.54.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
2023-07-03 $10.35 $10.42 $10.00 $10.11 90 496
2023-06-30 $10.67 $10.89 $10.33 $10.35 158 067
2023-06-29 $10.34 $10.80 $10.17 $10.74 98 227
2023-06-28 $10.35 $10.51 $10.08 $10.42 169 200
2023-06-27 $10.99 $10.99 $10.40 $10.42 162 055
2023-06-26 $11.46 $11.50 $10.33 $11.03 443 152
2023-06-23 $11.70 $12.02 $11.05 $11.46 2 110 082
2023-06-22 $11.83 $12.06 $11.70 $11.92 198 317
2023-06-21 $11.50 $12.20 $11.39 $11.98 248 229
2023-06-20 $12.30 $12.30 $11.62 $11.69 245 251
2023-06-16 $12.21 $12.49 $11.54 $12.00 195 008
2023-06-15 $12.49 $13.17 $11.89 $12.29 133 503
2023-06-14 $12.50 $13.10 $12.44 $12.49 140 682
2023-06-13 $11.89 $12.77 $11.89 $12.34 220 857
2023-06-12 $11.81 $12.41 $11.52 $12.01 198 657
2023-06-09 $10.99 $11.75 $10.78 $11.65 129 559
2023-06-08 $10.70 $11.15 $10.45 $11.06 111 090
2023-06-07 $10.53 $10.68 $10.26 $10.62 186 575
2023-06-06 $9.59 $10.80 $9.55 $10.49 118 612
2023-06-05 $9.73 $9.92 $9.54 $9.59 71 596
2023-06-02 $9.86 $9.99 $9.70 $9.74 109 091
2023-06-01 $9.91 $9.97 $9.60 $9.77 109 217
2023-05-31 $9.53 $10.11 $9.28 $9.90 304 799
2023-05-30 $9.85 $10.12 $9.37 $9.52 104 084
2023-05-26 $9.94 $10.82 $9.84 $9.97 147 885
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT